ARCHIVES

ACS Concludes That Laetrile Organization Is Insignificant

This article is from The Cancer Letter archive.

Vol. 17 No. 46 | November 29, 1991

Download PDF Visit The Full Archive

Related Articles

FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA

July 3, 1981

Concepts Approved For Developmental Therapeutics Program

June 19, 1987

Three Institutions In Texas To Form Center For Childhood Cancer Epidemiology Research.

February 2, 2001

Sledge Elected ASCO President

January 16, 2009

Solomon Garb’s Questions/Answers

December 19, 1980

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

March 26, 2010